New study aims to close diabetes care gap with smart insulin pumps

NCT ID NCT06236607

Recruiting now Disease control Sponsor: Boston Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether automated insulin pumps (hybrid closed loop systems) can help underserved adults with type 1 diabetes better control their blood sugar. About 140 participants will be randomly assigned to use one of three FDA-approved pump systems or continue with standard injections and glucose monitoring. The goal is to see if these pumps improve time in healthy blood sugar range and reduce dangerous highs and lows over 9 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetes Complications diabetic ketoacidosis type 1 diabetes mellitus type 1 diabetes mellitus 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES COMPLICATIONS DIABETES MELLITUS, TYPE 1

Contacts and locations

Locations

Boston Medical Center
RECRUITING

Boston, Massachusetts, 02118, United States
Montefiore Einstein Medical Center
RECRUITING

The Bronx, New York, 10467, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.